The Sr. Director of Business Development will drive Kyverna's growth strategy through strategic partnerships, licensing, and collaboration in the biopharmaceutical sector.

The Associate Director will lead SEC reporting, technical accounting, and SOX compliance, ensuring timely filings and guiding cross-functional teams in complex accounting matters.

The VP of Commercial Operations will lead and build commercial infrastructure, manage sales field operations, and oversee analytics for cell therapies targeting autoimmune diseases. They will collaborate with cross-functional teams to ensure effective commercialization and launch of products, while developing a high-performing operations team.